Realizing the Potential of Plasma Genotyping in an Age of Genotype-Directed Therapies

The identification of oncogenic driver mutations in cancer has led to the rapid rise of genotype-directed treatments such as EGFR and BRAF kinase inhibitors. Standard tumor biopsy remains a cumbersome and morbid procedure for patients, leading to a growing interest in noninvasive plasma genotyping a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Natl Cancer Inst
Hlavní autoři: Luke, Jason J., Oxnard, Geoffrey R., Paweletz, Cloud P., Camidge, D. Ross, Heymach, John V., Solit, David B., Johnson, Bruce E.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2014
Témata:
Commentary
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6281080/
https://ncbi.nlm.nih.gov/pubmed/25106647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/dju214
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky